Meletios Therapeutics
Meletios Therapeutics is an operator of a biotechnology company intended to fulfill the medical need for antiviral molecules against current and emerging diseases. The company offers antiviral drugs by targeting host mechanisms that are hijacked by viruses, enabling healthcare institutions to treat a range of pathologies.
Industries
biotechnology
therapeutics
wellness
Nr. of Employees
small (1-50)
Products
MLT103
MLT103 is a small molecule drug candidate with immunomodulatory activity targeting respiratory viral infections and inflammation.
Defective Viral Genomes (DVG) Platform
A platform developing RNA biologics that interfere with viral protein expression machinery to treat RNA virus infections broadly.
MLT103
MLT103 is a small molecule drug candidate with immunomodulatory activity targeting respiratory viral infections and inflammation.
Defective Viral Genomes (DVG) Platform
A platform developing RNA biologics that interfere with viral protein expression machinery to treat RNA virus infections broadly.